Mikaël Feracci

490 total citations
15 papers, 238 citations indexed

About

Mikaël Feracci is a scholar working on Molecular Biology, Cell Biology and Infectious Diseases. According to data from OpenAlex, Mikaël Feracci has authored 15 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 3 papers in Cell Biology and 2 papers in Infectious Diseases. Recurrent topics in Mikaël Feracci's work include RNA modifications and cancer (5 papers), RNA Research and Splicing (4 papers) and Hippo pathway signaling and YAP/TAZ (3 papers). Mikaël Feracci is often cited by papers focused on RNA modifications and cancer (5 papers), RNA Research and Splicing (4 papers) and Hippo pathway signaling and YAP/TAZ (3 papers). Mikaël Feracci collaborates with scholars based in France, United Kingdom and United States. Mikaël Feracci's co-authors include Cyril Dominguez, Philippe Roche, Françoise Guerlesquin, Claudine Schiff, Marion Espéli, Laurent Hoffer, Xavier Morelli, S. Betzi, Olivier Bornet and Marina Danilenko and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Mikaël Feracci

15 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mikaël Feracci France	8	195	66	31	17	15	15	238
Afoma C. Umeano United States	6	189 1.0×	84 1.3×	47 1.5×	31 1.8×	37 2.5×	10	313
Christina Gros France	11	390 2.0×	31 0.5×	36 1.2×	30 1.8×	6 0.4×	15	460
Sally Esmail Canada	8	179 0.9×	51 0.8×	15 0.5×	15 0.9×	4 0.3×	12	257
Yukiko Misawa Japan	7	319 1.6×	33 0.5×	32 1.0×	48 2.8×	15 1.0×	9	372
Ho-Tak Lau United States	9	237 1.2×	19 0.3×	18 0.6×	26 1.5×	11 0.7×	15	285
Jonah Beenstock Israel	9	357 1.8×	23 0.3×	32 1.0×	51 3.0×	15 1.0×	16	418
Sasha Pantel United States	4	303 1.6×	16 0.2×	29 0.9×	65 3.8×	12 0.8×	4	336
Sarah J. Backe United States	10	373 1.9×	49 0.7×	56 1.8×	30 1.8×	25 1.7×	26	446
Hardik Patel United States	7	297 1.5×	62 0.9×	11 0.4×	21 1.2×	64 4.3×	8	348
Thi Nhu Ngoc Van France	11	175 0.9×	40 0.6×	15 0.5×	58 3.4×	7 0.5×	16	284

Countries citing papers authored by Mikaël Feracci

Since Specialization

Citations

This map shows the geographic impact of Mikaël Feracci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikaël Feracci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikaël Feracci more than expected).

Fields of papers citing papers by Mikaël Feracci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikaël Feracci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikaël Feracci. The network helps show where Mikaël Feracci may publish in the future.

Co-authorship network of co-authors of Mikaël Feracci

This figure shows the co-authorship network connecting the top 25 collaborators of Mikaël Feracci. A scholar is included among the top collaborators of Mikaël Feracci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikaël Feracci. Mikaël Feracci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Feracci, Mikaël, Sergio Hernández, Renaud Vincentelli, et al.. (2024). Biophysical and structural study of La Crosse virus endonuclease inhibition for the development of new antiviral options. IUCrJ. 11(3). 374–383. 3 indexed citations

Feracci, Mikaël, Adel Moussa, Steven S. Good, et al.. (2024). The activation cascade of the broad-spectrum antiviral bemnifosbuvir characterized at atomic resolution. PLoS Biology. 22(8). e3002743–e3002743. 3 indexed citations

Shannon, Ashleigh, Mikaël Feracci, Véronique Fattorini, et al.. (2023). An exonuclease-resistant chain-terminating nucleotide analogue targeting the SARS-CoV-2 replicase complex. Nucleic Acids Research. 52(3). 1325–1340. 6 indexed citations

Hoffer, Laurent, Raphaël Leblanc, Mikaël Feracci, et al.. (2023). Discovery of a PDZ Domain Inhibitor Targeting the Syndecan/Syntenin Protein–Protein Interaction: A Semi-Automated “Hit Identification-to-Optimization” Approach. Journal of Medicinal Chemistry. 66(7). 4633–4658. 4 indexed citations

Hernández, Sergio, Mikaël Feracci, Fabrice Bailly, et al.. (2022). Identification of potent inhibitors of arenavirus and SARS-CoV-2 exoribonucleases by fluorescence polarization assay. Antiviral Research. 204. 105364–105364. 4 indexed citations

Hoffer, Laurent, Raphaël Leblanc, Mikaël Feracci, et al.. (2021). Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spread. European Journal of Medicinal Chemistry. 223. 113601–113601. 9 indexed citations

Grand, Marion Le, Laurent Hoffer, S. Betzi, et al.. (2020). In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor. Molecular Oncology. 14(12). 3083–3099. 22 indexed citations

Leblanc, Raphaël, Rudra Kashyap, Karine Barral, et al.. (2020). Pharmacological inhibition of syntenin PDZ2 domain impairs breast cancer cell activities and exosome loading with syndecan and EpCAM cargo. Journal of Extracellular Vesicles. 10(2). e12039–e12039. 39 indexed citations

Feracci, Mikaël, Sushma Nagaraja Grellscheid, Marina Danilenko, et al.. (2016). Structural basis of RNA recognition and dimerization by the STAR proteins T-STAR and Sam68. Nature Communications. 7(1). 10355–10355. 50 indexed citations

10.

Danilenko, Marina, Caroline Dalgliesh, Vittoria Pagliarini, et al.. (2016). Binding site density enables paralog-specific activity of SLM2 and Sam68 proteins in Neurexin2 AS4 splicing control. Nucleic Acids Research. 45(7). gkw1277–gkw1277. 13 indexed citations

11.

Feracci, Mikaël, et al.. (2014). Structural investigations of the RNA-binding properties of STAR proteins. Biochemical Society Transactions. 42(4). 1141–1146. 1 indexed citations

12.

Feracci, Mikaël, et al.. (2013). Screening protein – Single stranded RNA complexes by NMR spectroscopy for structure determination. Methods. 65(3). 288–301. 15 indexed citations

13.

Espéli, Marion, Annie Boned, Olivier Bornet, et al.. (2012). Structural Basis for Galectin-1-dependent Pre-B Cell Receptor (Pre-BCR) Activation. Journal of Biological Chemistry. 287(53). 44703–44713. 44 indexed citations

14.

Feracci, Mikaël, Olivier Bornet, Philippe Roche, et al.. (2011). MEMO associated with an ErbB2 receptor phosphopeptide reveals a new phosphotyrosine motif. FEBS Letters. 585(17). 2688–2692. 6 indexed citations

15.

Feracci, Mikaël, Marion Espéli, Florence Chaspoul, et al.. (2009). NMR and MD Investigations of Human Galectin-1/Oligosaccharide Complexes. Biophysical Journal. 97(12). 3168–3177. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact